Assembly Biosciences, Inc. (ASMB) Misses Q1 EPS by $1.39

Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q1 EPS of ($1.66), $1.39 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $5.79 million.

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Cal-Maine Foods (CALM) PT Lowered to $85 at Stephens
• Tower Semiconductor shares jump on $3B Japan expansion